Dementia and Alzheimer Disease

Epilepsy

Headache and Migraine

Movement Disorders

Multiple Sclerosis

Neuromuscular

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Medcast Podcasts

Medcast Videos

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

International Journal of MS Care

Resources

Disease Spotlight

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

eNewsletter

Print Subscription

Articles

In a recent post hoc analysis of the Study C021 trial, findings support the idea that early adjustments to concomitant antiseizure medications enhance the retention of cenobamate, an FDA-approved treatment for focal seizures.

Adjusting Antiseizure Medication Dosages Improves Retention of Cenobamate

Videos

The professor of neurology in the department of neuroscience at Monash University discussed implementation strategies for treatment approaches to achieve seizure freedom in patients with epilepsy. [WATCH TIME: 5 minutes] 

Empowering Patient Voice in Epilepsy Treatment and Strategies for Seizure Freedom: Patrick Kwan, MD, PhD, FRCP

Over a 12-week trial period, Asian patients treated with brivaracetam demonstrated efficacy and safety outcomes that were similar to other populations previously observed.

Efficacy and Safety of Antiseizure Medication Brivaracetam Maintained in Asian Patients

Neurology News Network for the week ending December 1, 2023. [WATCH TIME: 4 minutes]

Phase 2 Trial of Alzheimer Psychosis Initiated, FDA Declines to Lift Hold on ENTR-601-44, Levetiracetam and Clobazam With Safety Warnings

Division director of epilepsy and associate professor of neurology at The Ohio State University Wexner Medical Center.

The division director of epilepsy and associate professor of neurology at The Ohio State University Wexner Medical Center discussed the profound repercussion of ongoing seizures for patients with epilepsy which is to be presented at AES 2023 in SK Life Science’s symposium. [WATCH TIME: 5 minutes] 

Exploring the Hidden Burdens of Persistent Seizures for Patients: Danielle Becker, MD, MS, FAES

The neurologist at Cleveland Clinic provided perspective on the reasons to study individuals exposed to repetitive head impacts and the lessons learned about monitoring glial fibrillary acidic protein over time. [WATCH TIME: 4 minutes]

Role of Fluid Biomarkers and GFAP in Neurodegeneration: Charles Bernick, MD

Chief executive officer at Parkinson & Movement Disorder Alliance.

The chief executive officer at Parkinson & Movement Disorder Alliance and the president at PD Avengers discussed the importance of awareness in movement disorders and the challenges that patients still face in getting access to treatments for improved quality of life. [WATCH TIME: 12 minutes

Shining a Light on Movement Disorders, Advocating for Awareness and Access to Care: Andréa Merriam & Larry Gifford

, has been with the team since October 2019. Follow him on Twitter 

The director of the headache section at Cleveland Clinic’s Neurological Institute provided thoughts on how recent advances have propelled migraine care, treatment possibilities behind prevention, and emerging research targets.

NeuroVoices: Emad Estemalik, MD, on Pioneering a New Age of Migraine Care

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

Twitter

LinkedIN

Spotlight

Narcolepsy

NMOSD

Ataxia

Parkinson Disease

AES 2023

AANEM 2023

CTAD 2023

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

 Peer Exchange video series features panels of expert physicians engaging in in-depth discussions about practice-changing treatments, challenges in care, and the future paradigm of management for neurologic diseases.

Peer Exchange

1rem

Advances in the Treatment of Spinal Muscular Atrophy

Overview of Spinal Muscular Atrophy

Phenotypes of Spinal Muscular Atrophy

Newborn Screening for Spinal Muscular Atrophy 

Genetic Testing for Spinal Muscular Atrophy

Motor Testing to Assess Patients With SMA

Involvement of Primary Care Physicians in Diagnosing SMA

Pulmonary Care for Patients With Spinal Muscular Atrophy

GI Complications in Patients With Spinal Muscular Atrophy

Multidisciplinary Approach to Treating SMA

Recent Approval of Zolgensma for SMA

STR1VE Trial of Onasemnogene Abeparvovec for SMA

SPR1NT Trial of Onasemnogene Abeparvovec for SMA

Nusinersen for Treatment of SMA

Nusinersen ENDEAR-SHINE and CHERISH-SHINE for SMA

Nusinersen Phase 2 NURTURE Trial for SMA

Risdiplam in Development for SMA

Clinical Trials for Risdiplam for SMA

Final Thoughts on Treating SMA